Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
PBA Pembina Pipeline Corp
ZTS Zoetis Inc
HMPT Home Point Capital Inc
KWR Quaker Chemical Corp
TWO Two Harbors Investment Corp
BV Brightview Holdings Inc
PBPB Potbelly Corp
RLJ RLJ Lodging Trust
LHCG LHC Group Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Closing Price
$116.08
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
6,301,980
0
  • Prev Close
    116.08
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    6.3M
  • Last (time)
    7:00p ET 05/06/21
  • Last (size)
    15
  • 52-Wk Range
    79.11 - 116.28
    LowHigh
  • (10/29/20 - 05/05/21)
    0.17%
  • 24.3%
  • Market Cap
    204.9B
  • Shares Outstanding
    1.8B
  • 2.71
  • 42.72x
  • $5.20/4.49%
  • Ex-dividend Date
    04/14/21
  • Dividend Pay Date
    05/14/21
  • 0.8
  • 67.36
  • (% of float 04/15/21)
    1.06

Latest News

May 03, 2021
6:53 am ET
Globe Newswire
April 30, 2021
9:31 am ET
PR Newswire
8:51 am ET
MarketWatch
7:46 am ET
MarketWatch
7:45 am ET
MarketWatch
7:45 am ET
MarketWatch
7:45 am ET
MarketWatch
April 28, 2021
2:09 pm ET
MarketWatch
April 23, 2021
6:40 am ET
Globe Newswire
April 08, 2021
8:50 am ET
PR Newswire
April 07, 2021
8:00 am ET
PR Newswire
April 02, 2021
5:18 pm ET
PR Newswire
April 01, 2021
11:00 pm ET
PR Newswire
10:30 pm ET
PR Newswire
8:31 am ET
PR Newswire
March 31, 2021
8:00 am ET
PR Newswire
March 30, 2021
8:00 am ET
PR Newswire
March 24, 2021
8:30 am ET
PR Newswire
6:16 am ET
Globe Newswire
March 21, 2021
11:34 pm ET
Newsfile
March 18, 2021
7:26 pm ET
PR Newswire
March 17, 2021
8:45 am ET
PR Newswire
March 11, 2021
8:18 am ET
Globe Newswire
March 10, 2021
4:06 am ET
Globe Newswire
February 25, 2021
8:00 am ET
PR Newswire
February 24, 2021
6:45 am ET
Globe Newswire
February 23, 2021
8:30 am ET
PR Newswire
February 22, 2021
1:37 pm ET
Globe Newswire
8:45 am ET
PR Newswire
February 19, 2021
9:15 am ET
PR Newswire
8:00 am ET
PR Newswire
February 18, 2021
10:58 am ET
PR Newswire
February 16, 2021
5:46 am ET
Globe Newswire
February 12, 2021
8:00 am ET
PR Newswire
February 11, 2021
9:01 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.